3M Q2 2026: Adjusted Metrics Impress, GAAP Burden Lingers

What happened

3M reported Q2 2026 adjusted organic growth of 5.4% and adjusted operating margin of 24.9%, both beating expectations, while GAAP operating margin fell 290 bps to 15.1% due to elevated litigation and PFAS costs. Management raised full-year adjusted EPS guidance to $8.80-$8.95, signaling confidence in operational momentum. However, GAAP EPS of $1.78 remains heavily adjusted, and operating cash flow of $1.0B was modest relative to adjusted net income. The improvement in adjusted metrics supports the turnaround narrative, but the persistent GAAP margin gap underscores the weight of legacy liabilities.

Implication

Over a longer horizon, the success of the 3M eXcellence program is critical to closing the GAAP-adjusted gap. If litigation cash flows remain within schedules and free cash flow conversion normalizes above 100%, the stock could approach our bull case of $180. However, any slippage in liability management or margin execution could see it fall to our bear case of $120. Monitor GAAP free cash flow and net debt trends closely.

Thesis delta

The Q2 results and raised guidance confirm that operational self-help is on track, reducing near-term downside risk. However, the wide GAAP-adjusted gap and still-elevated net debt mean the base case scenario remains more likely than a rapid re-rating to bull case. The thesis shifts modestly positive: we would move from 'potential sell' to 'hold' at current levels, awaiting further de-risking of the balance sheet before upgrading.